undamentalytics Newsletter

Institution

Tpg Gp A, LLC

13F for the quarter to June 30, 2026, filed August 14, 2026 · SEC CIK 1903793

Reported value
$5.0bn
84% in companies we cover
Positions we cover
27
Largest LFST 23.9%
Copy, a year
+16.0%
S&P 500 +14.1%
Copy Sharpe ratio
0.50
S&P 500 0.63

How copying its 13F would have done

$10.0k$20.0k 20222023202420252026 $20.1k$18.6k
CopyS&P 500 $10,000 copying Tpg Gp A, LLC's filed holdings in companies we cover from February 18, 2022, buying on the first trading day after each 13F was filed and holding until the next, against the S&P 500 (total return). Marked weekly, log scale. Before costs and taxes; misses trading within each quarter and anything 13F does not show (shorts, cash, bonds, non-US holdings).

Biggest drop −28.7% (S&P 500 −20.5%); beta 1.18; alpha +2.8% a year (t = 0.27); last 12 months +69.4% against +12.1%.

Reported value by quarter

Tpg Gp A, LLC: 13F reported value Total value of all positions in each quarter's 13F, as filed (values before 2023 were filed in thousands of dollars and are converted).
$0 $2T $4T $6T Reported value, 2021-12-31: $10B Reported value, 2022-03-31: $8.1B Reported value, 2022-06-30: $6.5B Reported value, 2022-09-30: $6.1B Reported value, 2022-12-31: $5.1T Reported value, 2023-03-31: $6.1B Reported value, 2023-06-30: $6.8B Reported value, 2023-09-30: $5.7B Reported value, 2023-12-31: $6.2B Reported value, 2024-03-31: $5.2B Reported value, 2024-06-30: $2.1B Reported value, 2024-09-30: $5.9B Reported value, 2024-12-31: $6.2B Reported value, 2025-03-31: $5B Reported value, 2025-06-30: $1.9B Reported value, 2025-09-30: $1.8B Reported value, 2025-12-31: $2.7B Reported value, 2026-03-31: $3.7B Reported value, 2026-06-30: $5B 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2026-06-30 $5B
View chart data
Period Reported value
2021-12-31 $10B
2022-03-31 $8.1B
2022-06-30 $6.5B
2022-09-30 $6.1B
2022-12-31 $5.1T
2023-03-31 $6.1B
2023-06-30 $6.8B
2023-09-30 $5.7B
2023-12-31 $6.2B
2024-03-31 $5.2B
2024-06-30 $2.1B
2024-09-30 $5.9B
2024-12-31 $6.2B
2025-03-31 $5B
2025-06-30 $1.9B
2025-09-30 $1.8B
2025-12-31 $2.7B
2026-03-31 $3.7B
2026-06-30 $5B

Holdings and moves

CompanyShare of portfolioValueSharesChange in shares
LFSTLifestance Health Group, Inc.23.93%$1.2bn111.74M−20.2% Reduced
SPCXSpace Exploration Technologies Corp14.69%$734.7m4.30MNew
JXNJackson Financial Inc.9.65%$482.8m4.72M0.0%
LTHLife Time Group Holdings, Inc.6.45%$322.4m7.89M−55.7% Reduced
SIONSionna Therapeutics, Inc.5.71%$285.7m6.49M0.0%
BETABeta Technologies, Inc.5.49%$274.6m16.40M0.0%
AMRXAmneal Pharmaceuticals, Inc.4.27%$213.4m12.33M0.0%
INVHInvitation Homes2.48%$124.3m4.11MNew
NGLNGL Energy Partners LP1.84%$92.1m5.78M−2.5% Reduced
BCAXBicara Therapeutics Inc.1.79%$89.4m3.01M0.0%
CBLLCeribell, Inc.1.46%$73.2m3.76M−5.2% Reduced
ODTXOdyssey Therapeutics, Inc.1.38%$69.0m3.69MNew
ACHVAchieve Life Sciences, Inc.0.90%$44.9m6.88MNew
ALLOAllogene Therapeutics, Inc.0.78%$38.9m18.72M0.0%
NXQuanex Building Products Corp0.77%$38.3m2.05M0.0%
NVRIEnviri Corp0.51%$25.6m1.16MNew
AVLNAvalyn Pharma Inc.0.51%$25.4m773.1KNew
TRTXTPG RE Finance Trust, Inc.0.40%$20.0m2.39M0.0%
NSCNorfolk Southern0.25%$12.6m40.0K0.0%
KVUEKenvue0.15%$7.6m400.0K+33.3% Added
PENPenumbra Inc0.13%$6.3m20.0K0.0%
RLYBRallybio Corp0.12%$6.1m378.6K0.0%
MITTTPG Mortgage Investment Trust, Inc.0.05%$2.3m288.3K0.0%
AESAES Corporation0.04%$2.2m150.0KNew
TECHBio-Techne0.04%$2.1m30.0KNew
CHMICherry Hill Mortgage Investment Corp0.03%$1.7m734.8K+32.0% Added
PAYOPayoneer Global Inc.0.01%$478,15683.9K0.0%
CompanyBought (value)Shares
SPCXSpace Exploration Technologies Corp$734.7m4.30M
INVHInvitation Homes$124.3m4.11M
ODTXOdyssey Therapeutics, Inc.$69.0m3.69M
ACHVAchieve Life Sciences, Inc.$44.9m6.88M
NVRIEnviri Corp$25.6m1.16M
AVLNAvalyn Pharma Inc.$25.4m773.1K
AESAES Corporation$2.2m150.0K
TECHBio-Techne$2.1m30.0K
KVUEKenvue$1.9m100.0K
CHMICherry Hill Mortgage Investment Corp$413,412178.2K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanySold (value)Shares
LTHLife Time Group Holdings, Inc.−$405.8m−9.94M
LFSTLifestance Health Group, Inc.−$302.9m−28.28M
CBLLCeribell, Inc.−$4.0m−206.3K
SLABSilicon Laboratories Inc.−$3.1m−15.0K
NGLNGL Energy Partners LP−$2.4m−150.2K
RVMDRevolution Medicines, Inc.−$243,125−2.5K
CORZCore Scientific, Inc.−$149,600−10.0K

Change in shares on the previous quarter's 13F, valued at this quarter's reported price.

CompanyValue last quarterShares
SLABSilicon Laboratories Inc.$3.1m15.0K
RVMDRevolution Medicines, Inc.$243,1252.5K
CORZCore Scientific, Inc.$149,60010.0K
  • Health Care48.9%
  • Industrials25.9%
  • Financials12.1%
  • Consumer Discretionary7.7%
  • Real Estate3.0%
  • Energy2.2%
  • Consumer Staples0.2%
  • Utilities0.1%

Share of the value held in companies we cover, by sector.

PeriodCopy, a yearS&P 500SharpeS&P 500Biggest dropBeta
Whole backtestFebruary 18, 2022 to November 2, 2026+16.0%+14.1%0.500.63−28.7%1.18
Last three yearsNovember 3, 2023 to November 2, 2026+32.1%+21.8%1.051.16−19.1%0.92
Last yearNovember 7, 2025 to November 2, 2026+52.4%+14.2%1.550.84−14.5%0.93

From SEC Form 13F data sets. A 13F lists long positions in US-listed shares at the quarter's end, filed up to 45 days later; it does not show shorts, cash, bonds, non-US holdings or trades within the quarter. Positions in companies outside our coverage are not listed here. Research, not investment advice.